Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy is a research paper published in The FASEB Journal (2022). On theSindex it has a DataRank of 0.554. It has been cited 14 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0.148
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR059810
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR068313
NIAMS NIH HHS
Grant: R01 AR059810
NIAMS NIH HHS
Grant: R01 AR068313
National Institutes of Health
Grant: 5R01AR068313-03
MYD88 Signaling in Mammalian Myoblast Fusion
National Institutes of Health
Grant: 2R01AR059810-06A1
TAK1 signaling in skeletal muscle
FWCI
1.02
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals